Customs Watch Listed by thegentlemen Ransomware Group: What Was Exposed & What To Do
Customs Watch was listed by thegentlemen ransomware group on July 16, 2026, with internal files reported as exfiltrated. Individuals connected to the organisation should check whether their data has been exposed and take appropriate protective steps.
What happened
Customs Watch was listed by thegentlemen ransomware group on July 16, 2026. The listing states that internal files were exfiltrated during a ransomware attack. No figure for the volume of data or the number of people affected has been released, and no independent confirmation of the claims has been made public.
Inside thegentlemen
Thegentlemen is a ransomware operation that publishes stolen data on a leak site when victims do not meet its demands. Groups of this type commonly combine encryption of systems with the threat of data release to increase pressure on targeted organisations. Public records show the group has previously listed companies across multiple sectors, though specific claims about any single victim require separate verification.
About Customs Watch
Customs Watch is an intelligence and IT consulting firm founded in 2001 that specialises in anti-counterfeiting and product-protection services, primarily for pharmaceutical manufacturers. It works with 22 of the 25 largest pharmaceutical companies worldwide and maintains membership in the International AntiCounterfeiting Coalition. The firm employs between 51 and 200 people and handles sensitive commercial and regulatory information in the course of its work.
The information in question
The listing refers only to internal files exfiltrated in a ransomware attack. No further breakdown of file types, client records, or personal data categories has been provided. Organisations in this sector routinely hold client contact details, regulatory correspondence, investigative reports, and internal operational documents, but the exact material involved in this incident is unconfirmed.
What's at stake
Exposure of internal files from a firm that advises major pharmaceutical companies could reveal details about product-protection strategies, regulatory processes, or business relationships. For individuals whose contact information or professional records appear in those files, the main risks are targeted phishing, unsolicited contact, or secondary misuse of the data. For the organisation, the incident adds operational disruption and potential loss of client confidence.
What to do if you're exposed
Review any recent or unusual emails that reference Customs Watch or pharmaceutical anti-counterfeiting work and treat unexpected attachments or links with caution. Monitor accounts associated with any email addresses that may have been shared with the company. Readers can run a free exposure scan of their email address to check whether their information has appeared in known breach data.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
Buck Knives Listed by thegentlemen Ransomware GroupDisney Family Listed by thegentlemen Ransomware GroupDisney Family Listed by thegentlemen Ransomware GroupAffinity Designs Listed by thegentlemen Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the Customs Watch Listed by thegentlemen Ransomware Group →
Publicly posted by thegentlemen — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.